Cargando…
Protection and Polyfunctional T Cells Induced by Ag85B-TB10.4/IC31® against Mycobacterium tuberculosis Is Highly Dependent on the Antigen Dose
BACKGROUND: Previously we have shown that Ag85B-TB10.4 is a highly efficient vaccine against tuberculosis when delivered in a Th1 inducing adjuvant based on cationic liposomes. Another Th1 inducing adjuvant, which has shown a very promising profile in both preclinical and clinical trials, is IC31®....
Autores principales: | Aagaard, Claus, Hoang, Truc Thi Kim Thanh, Izzo, Angelo, Billeskov, Rolf, Troudt, JoLynn, Arnett, Kim, Keyser, Andrew, Elvang, Tara, Andersen, Peter, Dietrich, Jes |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691953/ https://www.ncbi.nlm.nih.gov/pubmed/19529771 http://dx.doi.org/10.1371/journal.pone.0005930 |
Ejemplares similares
-
CD4 and CD8 T Cell Responses to the M. tuberculosis Ag85B-TB10.4 Promoted by Adjuvanted Subunit, Adenovector or Heterologous Prime Boost Vaccination
por: Elvang, Tara, et al.
Publicado: (2009) -
Distinct Differences in the Expansion and Phenotype of TB10.4 Specific CD8 and CD4 T Cells after Infection with Mycobacterium tuberculosis
por: Hoang, Truc Thi Kim Thanh, et al.
Publicado: (2009) -
ESAT-6 (EsxA) and TB10.4 (EsxH) Based Vaccines for Pre- and Post-Exposure Tuberculosis Vaccination
por: Hoang, Truc, et al.
Publicado: (2013) -
Comparison of the Predicted Population Coverage of Tuberculosis Vaccine Candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a Bioinformatics Approach
por: Davila, Jose, et al.
Publicado: (2012) -
Correction: Comparison of the Predicted Population Coverage of Tuberculosis Vaccine Candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a Bioinformatics Approach
por: Davila, Jose, et al.
Publicado: (2012)